MedPath

Apixar

Brand Name: Apixar

Generic Name: Apixaban

Active
Registration Number

DRP-16370

Dosage Form

Film Coated Tablet

Issuance Date

February 20, 2025

Expiry Date

February 20, 2030

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2.5 mg
PackagingAlu/PVC/PVDC Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antithrombotic Agent (Direct Factor Xa Inhibitor)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

ApixabanActive
Monograph: Apixaban

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform